Shanghai Shenqi Pharmaceutical Investment Management Co Ltd. Stock Analysis 600613.SS

Shanghai Shenqi Pharmaceutical Investment Management Co., Ltd. engages in the research, development, production and sale of pharmaceuticals. The company is headquartered in Shanghai, Shanghai and currently employs 1,266 full-time employees. The firm's products cover therapeutic areas such as anti-tumor, cold and cough, cardiovascular and cerebrovascular, rheumatic and bone pain, antifungal, tonic and tranquilizing, and gynecological. The Company’s main products include sodium cantharidinate and vitamin B6 injection, sodium cantharidinate injection, loquat cough granules, strong loquat dew, loquat cough capsules, Jinwu Gutong capsules, Shanhu Xuanjing, Jingwu capsules, Quantianma capsules, and Yindan Xintai dripping pills. The firm distributes its products within the domestic market and to overseas markets.